Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma

NCT02098538 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Adenoid Cystic Carcinoma

Interventions

DRUG: Regorafenib

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]